ImmunityBio, Inc

Help us find the next generation of treatments for cancer and infectious diseases

If you’re passionate about our mission to discover innovative biotechnologies and love the challenges that come with a fast-paced, collaborative environment, we want to hear from you!

ImmunityBio is looking for talented and dedicated individuals to join our diverse, rapidly growing team of professionals in every area of our business…people who are interested in adding their skills, energy, and vision to a goal with meaning: To discover, develop and bring to market innovative therapies and technologies that target some of the most difficult-to-treat and serious human diseases. We want to help prevent, treat and even cure cancers and infectious diseases from COVID to HIV to Tuberculosis, helping patients around the world and changing the future of medicine. We have a strong pipeline and ground-breaking research, and in addition to competitive compensation and great benefits, we offer our people diverse opportunities for career growth, as well as an ownership stake in the company’s success.

3530 John Hopkins Court
San Diego, CA 92121

Visit website

NEWS

Hand holding pencil erasing an employee. Dismissal or bankrumptcy concept. Vector illustration.

Layoffs

ImmunityBio Continues Trimming Workforce While Working to Advance Anktiva

ImmunityBio will part with 10 employees this quarter. Last fall, it cut 31 employees. The moves come as the biotech works to advance Anktiva in non-small cell lung cancer.

January 31, 2025

1 min read

Angela Gabriel

Silhouette of a business person on the top of a mountain peak in sunset background. Winner and conquer of businessman concept.

Regulatory

5 Companies That Celebrated First Approvals in 2024

Madrigal Pharmaceuticals, X4 Pharmaceuticals and Day One Biopharmaceuticals secured their maiden approvals this year in metabolic dysfunction-associated steatohepatitis, WHIM syndrome and pediatric low-grade glioma. Geron Corporation and ImmunityBio also notched wins.

December 23, 2024

6 min read

Heather McKenzie

Giant robot flicking tiny man. Ai technologies and unemployment problem concept. Vector illustration.

Layoffs

More Layoffs From ImmunityBio, Bringing California’s Fall Cuts to 31

ImmunityBio will lay off 15 employees in California, mostly in El Segundo, effective Nov. 25. The company is also letting go 16 employees later this month.

October 2, 2024

1 min read

Angela Gabriel

Job Trends

California Tops Biopharma Job Openings So Far in 2024, Per BioSpace Data

For the first eight months of 2024, California had the most job postings live on BioSpace—37.7% more than Massachusetts. Last year, Massachusetts ranked No.1 for the same time period.

September 12, 2024

4 min read

Angela Gabriel

Employees Walking In And Out Of The Door, Some Were Leaving Their Job And Some Were Being Hired At The Same Time. Full Length, Isolated On Solid Color Background. Vector, Illustration, Flat Design, Character.

Layoffs

ImmunityBio to Lay Off 16, Will Likely Need Additional Capital

ImmunityBio will lay off 16 employees in California and said it expects to need more funding to commercialize Anktiva, approved in April for non-muscle invasive bladder cancer.

September 4, 2024

2 min read

Angela Gabriel

Pictured: 3D concept art showing a bladder surrounded by cancer cells

FDA

ImmunityBio Wins FDA Approval for First IL-15 Superagonist for NMIBC

Bouncing back from a previous rejection, ImmunityBio on Monday secured the FDA’s green light for its IL-15 superagonist Anktiva for non-muscle invasive bladder cancer.

April 23, 2024

2 min read

Tristan Manalac